Edmund Ingham | INCY Incyte: Good Company, But Potentially Overvalued Given Patent Cliffs ByMario Cazombo May 29, 2025
EA | OTGLF | OTGLY | Simple Investment Ideas | TTWO CD Projekt: AI Catalyst Poised To Slash Development Cycles And Boost Margins ByMario Cazombo June 1, 2025
ENB | ENB:CA | ENLAY | MEGI | Nick Ackerman | Stanford Chemist MEGI: Discounted Infrastructure Exposure With Activist Potential ByMario Cazombo June 1, 2025
HESAF | HESAY | LVMHF | LVMUY | Millennial Dividends | SP500 LVMH: The Worst May Be Behind Us With Recovery Underway ByMario Cazombo May 30, 2025
AB | AMG | CNS | David Johnson | IVZ | JHG | MGR | MGRB | MGRD | MGRE | VCTR | XLF Affiliated Managers Group Q1: Declines In All Key Metrics ByMario Cazombo May 30, 2025
ALSN | Volatility and Reason Allison Transmission: An Industrial Leader With Fortitude, But Valuation Calls For Patience ByMario Cazombo May 26, 2025
BBWI | SA Transcripts Bath & Body Works, Inc. 2025 Q1 – Results – Earnings Call Presentation ByMario Cazombo May 29, 2025
